Chancery Refuses Toss Of Biotech Firm Share Award Suit
Unjust enrichment and fiduciary breach claims against six directors or officers of biotech venture Northwest Biotherapeutics moved toward trial late Friday after a Delaware vice chancellor refused to dismiss claims that...To view the full article, register now.
Already a subscriber? Click here to view full article